Results 11 to 20 of about 12,137 (255)

Bumetanide increases Cl--dependent short-circuit current in late distal colon: Evidence for the presence of active electrogenic Cl- absorption.

open access: goldPLoS ONE, 2017
Mammalian colonic epithelia consist of cells that are capable of both absorbing and secreting Cl-. The present studies employing Ussing chamber technique identified two opposing short-circuit current (Isc) responses to basolateral bumetanide in rat ...
Lieqi Tang   +6 more
doaj   +2 more sources

Bumetanide for autism: more eye contact, less amygdala activation [PDF]

open access: goldScientific Reports, 2018
Nouchine Hadjikhani   +2 more
exaly   +2 more sources

Evaluation of bumetanide as a potential therapeutic agent for Alzheimer’s disease

open access: yesFrontiers in Pharmacology, 2023
Therapeutics discovery and development for Alzheimer’s disease (AD) has been an area of intense research to alleviate memory loss and the underlying pathogenic processes.
Ben Boyarko   +16 more
doaj   +1 more source

Loop diuretics association with Alzheimer’s disease risk

open access: yesFrontiers in Aging, 2023
Objectives: To investigate whether exposure history to two common loop diuretics, bumetanide and furosemide, affects the risk of developing Alzheimer’s disease (AD) after accounting for socioeconomic status and congestive heart failure.Methods ...
Anna Graber-Naidich   +7 more
doaj   +1 more source

Inhibition of NKCC1 attenuated hippocampal LTP formation and inhibitory avoidance in rat. [PDF]

open access: yesPLoS ONE, 2014
The loop diuretic bumetanide (Bumex) is thought to have antiepileptic properties via modulate GABAA mediated signaling through their antagonism of cation-chloride cotransporters.
Meng Chang Ko   +5 more
doaj   +1 more source

Nanoformulated Bumetanide Ameliorates Social Deficiency in BTBR Mice Model of Autism Spectrum Disorder

open access: yesFrontiers in Immunology, 2022
Autism spectrum disorder (ASD) is a prevalent neurodevelopmental disorder with few medication options. Bumetanide, an FDA-approved diuretic, has been proposed as a viable candidate to treat core symptoms of ASD, however, neither the brain region related ...
Hui Lv   +10 more
doaj   +1 more source

Decreased Immunoreactivities and Functions of the Chloride Transporters, KCC2 and NKCC1, in the Lateral Superior Olive Neurons of Circling Mice [PDF]

open access: yesClinical and Experimental Otorhinolaryngology, 2011
ObjectivesWe tested the possibility of differential expression and function of the potassium-chloride (KCC2) and sodium-potassium-2 chloride (NKCC1) co-transporters in the lateral superior olive (LSO) of heterozygous (+/cir) or homozygous (cir/cir) mice ...
Jonu Pradhan   +4 more
doaj   +1 more source

BUMETANIDE IN AUTISM SPECTRUM DISORDER

open access: yesArquivos de Ciências da Saúde da UNIPAR, 2022
Objectives: This study aimed to make a bibliographic update on the already published data on bumetanide, addressing the main information on its use in Autism Spectrum Disorder (ASD).
Lucas da Silva Moreira   +1 more
doaj   +1 more source

Treatment Effect of Bumetanide in Children With Autism Spectrum Disorder: A Systematic Review and Meta-Analysis

open access: yesFrontiers in Psychiatry, 2021
Background: The therapeutic effect of bumetanide on autism spectrum disorder (ASD) seems to be controversial. To obtain better evidence on the efficacy of bumetanide, a systematic review and meta-analysis were performed.Methods: Randomized, placebo ...
Tiantian Wang   +4 more
doaj   +1 more source

Neuronal and astroglial correlates underlying spatiotemporal Intrinsic Optical Signal in the rat hippocampal slice [PDF]

open access: yes, 2013
Widely used for mapping afferent activated brain areas in vivo, the label-free intrinsic optical signal (IOS) is mainly ascribed to blood volume changes subsequent to glial glutamate uptake.
Héja, László   +3 more
core   +7 more sources

Home - About - Disclaimer - Privacy